Skip to main content
. Author manuscript; available in PMC: 2015 Dec 30.
Published in final edited form as: Hematology Am Soc Hematol Educ Program. 2014 Nov 18;2014(1):531–535. doi: 10.1182/asheducation-2014.1.531

Figure 2. Decreased VWF:RCo/VWF:Ag ratio in healthy control subjects with p.D1472H.

Figure 2

This graph shows VWF:RCo/VWF:Ag ratios for healthy control subjects (59 African Americans and 113 Caucasians) enrolled in the US Zimmerman Program study, grouped by presence or absence of the p.D1472H sequence variation.7 Mean ratios for each group are shown at the top of the graph. There were 7 subjects with ratios <0.6, all either heterozygous or homozygous for p.D1472H. None of the subjects without p.D1472H had ratios <0.7.